Meta Platforms Price Target Cut By This Analyst, Plus BMO Capital Predicts $223 For Salesforce
Today, 5:30 PM
Morgan Stanley boosted the price target for Meta Platforms, Inc. (NASDAQ: META) from $280 to $225. Meta shares fell 2.1% to $171.01 in pre-market trading.
UBS Upgrades DaVita to Buy, Raises Price Target to $117
Today, 5:30 PM
UBS analyst Andrew Mok upgrades DaVita (NYSE:DVA) from Neutral to Buy and raises the price target from $106 to $117.
Deutsche Bank Maintains Buy on DaVita, Lowers Price Target to $97
Today, 5:30 PM
Deutsche Bank analyst Pito Chickering maintains DaVita (NYSE:DVA) with a Buy and lowers the price target from $150 to $97.
DaVita Q2 EPS $2.30 Beats $2.09 Estimate, Sales $2.93B Miss $2.93B Estimate
Today, 5:30 PM
DaVita (NASDAQ:DVA) reported quarterly earnings of $2.30 per share which beat the analyst consensus estimate of $2.09 by 10.05 percent. This is a 12.88 percent decrease over earnings of $2.64 per share from the same
Earnings Scheduled For August 1, 2022
Today, 5:30 PM
Companies Reporting Before The Bell
• Bon Natural Life (NASDAQ:BON) is projected to report earnings for its first quarter.
Why Shares Of DaVita Are Down Today
Today, 5:30 PM
Shares of DaVita Inc. (NYSE: DVA) are trading lower today in sympathy Fresenius Medical Care AG & Co (NYSE: FMS), which provided a bearish 2022 outlook and withdrew its 2025 targets.
10 Health Care Stocks With Whale Alerts In Today’s Session
Today, 5:30 PM
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
FCPT Announces Acquisition of a DaVita Kidney Care Property for $2.2 Million
Today, 5:30 PM
MILL VALLEY, Calif.--(BUSINESS WIRE)-- Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail
The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI’s Brain Cancer Vaccine, Xenon’s Epilepsy Candidate Shows Promise
Today, 5:30 PM
Here's a roundup of top developments in the biotech space over the last 24 hours: